sulfinpyrazone has been researched along with Diabetes Mellitus in 7 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dosage of sulfinpyrazone used in this trial was well tolerated by all patients and no side effects were observed." | 2.65 | [Interaction of sulfinpyrazone (Anturan) and glibenclamide (Euglucon) in type II diabetic patients]. ( Irsigler, K; Kritz, H; Najemnik, C, 1983) |
| "Gout is increasingly recognized as the most common form of inflammatory arthritis worldwide; however, no Canadian data on the disease burden of gout are available." | 1.46 | The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012. ( Aviña-Zubieta, JA; Choi, HK; De Vera, MA; McCormick, N; Rai, SK; Sayre, EC; Shojania, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rai, SK | 1 |
| Aviña-Zubieta, JA | 1 |
| McCormick, N | 1 |
| De Vera, MA | 1 |
| Shojania, K | 1 |
| Sayre, EC | 1 |
| Choi, HK | 1 |
| EHRENBOECK, R | 1 |
| Kritz, H | 1 |
| Najemnik, C | 1 |
| Irsigler, K | 1 |
| Morin, RJ | 1 |
| Chen, AF | 1 |
| Narayanan, AS | 1 |
| Raye, C | 1 |
| Moss, RA | 1 |
| Srikantaiah, MV | 1 |
| Barajas, L | 1 |
| Pannebakker, MA | 1 |
| den Ottolander, GJ | 1 |
| ten Pas, JG | 1 |
| Nenci, GG | 1 |
| Agnelli, G | 1 |
| Berrettini, M | 1 |
| Parise, P | 1 |
| Ballatori, E | 1 |
| Günther, R | 1 |
| Knapp, E | 1 |
2 trials available for sulfinpyrazone and Diabetes Mellitus
| Article | Year |
|---|---|
[Interaction of sulfinpyrazone (Anturan) and glibenclamide (Euglucon) in type II diabetic patients].
Topics: Adult; Aged; Clinical Trials as Topic; Diabetes Mellitus; Drug Interactions; Female; Glyburide; Huma | 1983 |
Insulin requirements in diabetic patients treated with sulphinpyrazone.
Topics: Adult; Aged; Body Weight; Diabetes Mellitus; Diabetic Nephropathies; Double-Blind Method; Drug Inter | 1979 |
5 other studies available for sulfinpyrazone and Diabetes Mellitus
| Article | Year |
|---|---|
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.
Topics: Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; British Columbia; Colchicine; Comorbidit | 2017 |
[GOUT AND ITS TREATMENT WITH ANTURANE].
Topics: Arthritis; Arthritis, Rheumatoid; Blood; Diabetes Mellitus; Drug Therapy; Gout; Humans; Obesity; Sul | 1965 |
Platelet adhesion to collagen in normal and von Willebrand's disease subjects.
Topics: Animals; Aspirin; Blood Platelets; Collagen; Diabetes Mellitus; Dipyridamole; Factor VIII; Humans; K | 1980 |
Inhibition of spontaneous platelet aggregation by sulfinpyrazone.
Topics: Aged; Arteriosclerosis; Diabetes Mellitus; Double-Blind Method; Humans; Hyperlipidemias; Male; Middl | 1979 |
[Clinical findings and therapy of gout with special reference to the metabolic effects of sulfinpyrazone (Anturan) and allopurinol (Zyloric)].
Topics: Allopurinol; Diabetes Mellitus; Gout; Humans; Hypertension; Kidney Diseases; Male; Sulfinpyrazone; U | 1969 |